The Association of Insulin-dextrose Treatment with Hypoglycemia in Patients with Hyperkalemia
Abstract Treatment of hyperkalemia with intravenous insulin-dextrose is associated with a risk of hypoglycemia. We aimed to determine the factors associated with hypoglycemia (glucose < 3.9 mmol/L, or < 70 mg/dL) and the critical time window with the highest incidence. In a retrospective cohor...
Guardado en:
Autores principales: | Ljiljana Crnobrnja, Manogna Metlapalli, Cathy Jiang, Mauli Govinna, Andy K. H. Lim |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fa92cf6cc11486cab1bbc645a32a5f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Observational study of the relative efficacy of insulin-glucose treatment for hyperkalaemia in patients with liver cirrhosis
por: Jeanette H Pham, et al.
Publicado: (2021) -
Association Between Knowledge of Hypoglycemia and Likelihood of Experiencing Hypoglycemia Among Patients with Insulin-Treated Diabetes Mellitus
por: Almigbal TH
Publicado: (2021) -
Management of Hyperkalemia in Heart Failure
por: Hakan Altay, et al.
Publicado: (2021) -
Hyperkalemia in chronic heart failure
por: Hakan Altay
Publicado: (2021) -
Letter to the editor regarding ‘‘Patiromer and Sodium Zirconium Cyclosilicate in Treatment of Hyperkalemia: A Systematic Review and Meta-analysis: Patiromer and Sodium Zirconium Cyclosilicate in Hyperkalemia’
por: Donna Zarzuela, PharmD, et al.
Publicado: (2021)